Interestingly, a recent study revealed that MLL1 histone methyltransferase is required for promoter methylation of MDR1 (multi drug resistance gene), a member of the ATP-binding cassette (ABC) transporter family that confers tumor drug resistance by actively effluxing a number of antitumor agents [35]. This evidence concerns the gene KMT2A and neoplasm.